Paul Maddison Selected Research

Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome)

1/2022	Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.
1/2019	The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
1/2018	Lambert-Eaton myasthenic syndrome and cerebellar ataxia: is Response to immunotherapy a clue to pathogenesis?
12/2012	Treatment in Lambert-Eaton myasthenic syndrome.
7/2012	The use of aminopyridines in neurological disorders.
6/2011	The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
2/2011	Treatment for Lambert-Eaton myasthenic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Maddison Research Topics

Disease

10	Myasthenia Gravis 01/2022 - 08/2002
7	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2022 - 02/2011
7	Neoplasms (Cancer) 01/2020 - 10/2010
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 12/2010
4	Nervous System Diseases (Neurological Disorders) 01/2019 - 07/2012
4	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 08/2002
4	Isaacs Syndrome (Neuromyotonia) 01/2017 - 08/2002
4	Muscular Diseases (Myopathy) 06/2013 - 10/2002
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 05/2017 - 09/2008
3	Lung Neoplasms (Lung Cancer) 01/2017 - 07/2011
2	Atrophy 01/2022 - 05/2017
2	Sensorineural Hearing Loss 01/2022 - 10/2002
2	Guillain-Barre Syndrome 01/2019 - 05/2018
2	Thymoma (Thymic Carcinoma) 09/2012 - 09/2003
1	Stroke (Strokes) 01/2022
1	Neuromuscular Junction Diseases 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Disease Progression 01/2019
1	Paraneoplastic Cerebellar Degeneration 01/2019
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2019
1	Myelitis 05/2018
1	Neurologic Manifestations (Neurological Manifestations) 04/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2018
1	Cerebellar Ataxia (Dysmetria) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 11/2017
1	Cataract (Cataracts) 05/2017
1	Seizures (Absence Seizure) 01/2017
1	Immune System Diseases (Immune Disorders) 01/2017
1	Glioma (Gliomas) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Epilepsy (Aura) 01/2016
1	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2014
1	Myoclonus (Nocturnal Myoclonus) 01/2014
1	Progressive Encephalomyelitis with Rigidity 01/2014
1	Acute Disease 01/2014
1	Malignant Hyperthermia 06/2013
1	Camptocormia 06/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2012
1	Sporadic Creutzfeldt-Jakob Disease 09/2012
1	Multiple Sclerosis 07/2012
1	Weight Loss (Weight Reduction) 03/2011
1	Erectile Dysfunction 03/2011
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 11/2010
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 09/2008
1	Neuromuscular Diseases (Neuromuscular Disease) 09/2003
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 10/2002
1	Ataxia (Dyssynergia) 10/2002
1	Channelopathies 08/2002
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2002
1	Myokymia 08/2002

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 01/2019 - 08/2002
9	AutoantibodiesIBA 01/2018 - 08/2002
8	AntigensIBA 01/2018 - 10/2010
4	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2017 - 09/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 10/2002
3	Cholinergic ReceptorsIBA 01/2022 - 08/2002
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2011
3	AmifampridineIBA 12/2012 - 02/2011
2	Immunoglobulins (Immunoglobulin)IBA 05/2018 - 09/2003
2	Anti-Idiotypic AntibodiesIBA 01/2011 - 10/2010
2	amphiphysinIBA 01/2011 - 10/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	glucose-mannose-glucoseIBA 01/2019
1	Circulating MicroRNAIBA 01/2018
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2018
1	GlycogenIBA 11/2017
1	GlucosidasesIBA 11/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016
1	Glycine Receptors (Glycine Receptor)IBA 01/2014
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2013
1	Annexin A1IBA 10/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2012
1	4-Aminopyridine (4 Aminopyridine)FDA Link 07/2012
1	AminopyridinesIBA 07/2012
1	DesminIBA 01/2012
1	AnnexinsIBA 07/2011
1	Rituximab (Mabthera)FDA Link 06/2011
1	muskIBA 06/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2011
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2011
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2010
1	Glu Transfer RNAIBA 11/2010
1	Calcium Channels (Calcium Channel)IBA 09/2008
1	Immunoglobulin G (IgG)IBA 09/2003
1	Ile Transfer RNAIBA 10/2002
1	NucleotidesIBA 10/2002
1	PotassiumIBA 08/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 06/2011
3	Immunotherapy 01/2018 - 01/2014
1	Immunomodulation 05/2017
1	Noninvasive Ventilation 05/2017
1	Plasmapheresis 09/2003